Barclays sets MetLife overweight rating, $91 target

EditorLina Guerrero
Published 04/09/2024, 22:22
Barclays sets MetLife overweight rating, $91 target
MET
-

On Wednesday, Barclays initiated coverage on MetLife Inc (NYSE:MET), a leading insurance and financial services company, with an Overweight rating and set a price target of $91.00. The firm's analysis highlighted MetLife's potential for sustained earnings growth, driven by its Group Benefits business in the United States and Mexico, as well as its expanding presence in Asia, particularly in non-Japan regions.

The Barclays report noted that MetLife has been effectively positioning itself for growth, which could lead to consistent earnings that outpace expectations. The company's Institutional markets segment has faced challenges due to increased funding costs linked to SOPHR (Secured Overnight Financing Rate) and lower returns from real estate investments. However, these areas could see improvements within the next 12 months.

Furthermore, Barclays pointed out that MetLife's multi-year disciplined approach to cash flow efficiency is yielding results, leading to a more reliable earnings stream. This focus on efficiency is expected to contribute to earnings beats and potentially enhance the company's valuation, which currently stands at approximately 7.5 times earnings.

Barclays' positive outlook on MetLife is based on these factors, suggesting that the company's strategic initiatives and operational focus are likely to support its financial performance going forward. The $91.00 price target reflects this confidence in MetLife's ability to maintain its earnings power and capitalize on growth opportunities in its key markets.

In other recent news, MetLife Investment Management (MIM), the asset management division of MetLife, Inc., has appointed Jude Driscoll as its new president. Driscoll, who formerly served as the global head of Fixed Income and Private Capital at MIM, is anticipated to guide MIM's strategic direction and operations, thereby enhancing client services and offerings. This is in line with the firm's growth strategy.

MetLife, in its recent earnings call, reported a robust performance for the second quarter of 2024. The company's earnings rose by 18% from the previous year to $1.6 billion. A significant contributor to this increase was the Group Benefits segment, which saw a 43% surge in adjusted earnings due to favorable underwriting and higher variable investment income.

Despite a slight 2% decline in Retirement and Income Solutions (RIS) earnings, MetLife maintained a strong recurring cash flow and solid capital and cash positions. The company's cash and liquid assets totaled $4.4 billion at the end of June.

As part of recent developments, MetLife is nearing the completion of its "Next Horizon" strategy and has announced the development of "New Frontier," a new five-year plan aimed at accelerating growth and enhancing returns.

InvestingPro Insights

As MetLife Inc (NYSE:MET) garners attention with Barclays' optimistic analysis, real-time data from InvestingPro complements the narrative of a company poised for growth. With a market capitalization of $54.24 billion, MetLife's financial stature is robust. The company's commitment to shareholder returns is evident, as highlighted by an impressive track record of raising its dividend for 11 consecutive years, a testament to its financial health and management's confidence in the company's future.

InvestingPro Tips further reveal that management's aggressive share buybacks and a consistent dividend payment history spanning 25 years underscore a shareholder-friendly approach. Moreover, MetLife's solid footing in the insurance industry is reinforced by a Price to Book ratio of 1.99 as of the last twelve months leading up to Q2 2024, indicating a potentially attractive valuation relative to its assets.

While the company's gross profit margin stands at 23.83% for the same period, reflecting competitive challenges, MetLife's liquid assets surpassing short-term obligations suggest a strong liquidity position. For investors seeking additional insights, InvestingPro offers more tips on MetLife, providing a deeper dive into the company's financial nuances and potential investment opportunities.

With a forward-looking stance, these InvestingPro data points and tips align with the article's narrative on MetLife's strategic growth and efficiency, further enriching the discussion for readers considering the company's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.